Literature DB >> 9593992

Indomethacin inhibits delayed DNA fragmentation of hippocampal CA1 pyramidal neurons after transient forebrain ischemia in gerbils.

F Kondo1, Y Kondo, M Gómez-Vargas, N Ogawa.   

Abstract

Recent studies have shown a close association between reactive oxygen species and DNA fragmentation and that delayed neuronal death after transient forebrain ischemia manifests as DNA fragmentation-like apoptosis. We examined the effect of indomethacin on ischemic-induced delayed hippocampal neuronal death in gerbils using the TUNEL staining method, since indomethacin is neuroprotective in a variety of degenerative processes, such as Alzheimer's disease. Indomethacin (5 mg/kg, i.p.), administered 5 min before the ischemic insult, significantly decreased the number of TUNEL-positive hippocampal CA1 pyramidal neurons and delayed the appearance of TUNEL-positive neurons. Our results indicate that indomethacin is effective in inhibiting DNA fragmentation after transient forebrain ischemia. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593992     DOI: 10.1016/s0006-8993(98)00211-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  3 in total

1.  Methylprednisolone and indomethacin inhibit oxidative stress mediated apoptosis in rat C6 glioblastoma cells.

Authors:  Arabinda Das; Naren L Banik; Swapan K Ray
Journal:  Neurochem Res       Date:  2007-06-15       Impact factor: 3.996

2.  Modulation of inflammatory response by selective inhibition of cyclooxygenase-1 and cyclooxygenase-2 in acute kidney injury.

Authors:  Carla Q Feitoza; Patricia Semedo; Giselle M Gonçalves; Marcos A Cenedeze; Hélady S Pinheiro; Oscar Fernando Pavão Dos Santos; Richardt Gama Landgraf; Alvaro Pacheco-Silva; Niels Olsen Saraiva Câmara
Journal:  Inflamm Res       Date:  2009-08-27       Impact factor: 4.575

3.  Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis.

Authors:  Carla Q Feitoza; Giselle M Gonçalves; Patrícia Semedo; Marcos A Cenedeze; Hélady S Pinheiro; Felipe Caetano Beraldo; Oscar Fernando Pavão dos Santos; Vicente de Paula A Teixeira; Marlene A dos Reis; Marilda Mazzali; Alvaro Pacheco-Silva; Niels O S Câmara
Journal:  Mol Med       Date:  2008-08-18       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.